期刊
JOURNAL OF BIOMOLECULAR NMR
卷 51, 期 3, 页码 395-408出版社
SPRINGER
DOI: 10.1007/s10858-011-9566-5
关键词
Ligand screening; Fragment-based drug design (FBDD); Protein-ligand structure; Lanthanide-binding peptide tag (LBT); Paramagnetic relaxation enhancement (PRE); Pseudo-contact shift (PCS)
资金
- Grants-in-Aid for Scientific Research [22570109] Funding Source: KAKEN
A nuclear magnetic resonance-based ligand screening strategy utilizing a paramagnetic lanthanide probe is presented. By fixing a paramagnetic lanthanide ion to a target protein, a pseudo-contact shift (PCS) and a paramagnetic relaxation enhancement (PRE) can be observed for both the target protein and its bound ligand. Based on PRE and PCS information, the bound ligand is then screened from the compound library and the structure of the ligand-protein complex is determined. PRE is an isotropic paramagnetic effect observed within 30 from the lanthanide ion, and is utilized for the ligand screening in the present study. PCS is an anisotropic paramagnetic effect providing long-range (similar to 40 ) distance and angular information on the observed nuclei relative to the paramagnetic lanthanide ion, and utilized for the structure determination of the ligand-protein complex. Since a two-point anchored lanthanide-binding peptide tag is utilized for fixing the lanthanide ion to the target protein, this screening method can be generally applied to non-metal-binding proteins. The usefulness of this strategy was demonstrated in the case of the growth factor receptor-bound protein 2 (Grb2) Src homology 2 (SH2) domain and its low- and high-affinity ligands.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据